Evidence map›Paper›PMID 34493032›Full record

ArticleTurkish journal of medical sciences2022

A COVID-19 first evaluation clinic at a university hospital in Turkey.

Gülçin Telli Dizman, Gökhan Metan, Çağlayan Merve Ayaz Ceylan, Hayriye Altunay, Mertcan Uzun, Gamze Gürsoy, Zahit Taş, Gizem Karahan, Farida Ahmadova, Tuğba Sarıcaoğlu and 13 more

Open access · bronzeAbstract read
In one paragraph

Article in Turkish journal of medical sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 2 institutions in 1 country.

Gülçin Telli DizmanDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Gökhan MetanInfection Control Committee, Hospitals of Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Çağlayan Merve Ayaz CeylanInfection Control Committee, Hospitals of Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Hayriye AltunayDepartment of Infectious Diseases, Siirt Training and Research Hospital, Siirt, Turkey.
Mertcan UzunDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Gamze GürsoyDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Zahit TaşDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Gizem KarahanDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Farida AhmadovaDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Tuğba SarıcaoğluDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Zeynep Cansu ÇalışkanDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Alpaslan AlpDepartment of Medical Microbiology, Faculty of Medicine, Hacettepe University Ankara, Turkey.
Meliha SönmezlerDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Ahmet İnkayaDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Şehnaz Özyavuz AlpDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Oğuz UyaroğluDepartment of Internal Medicine, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Ahmet ErDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Şehnaz Özyavuz AlpDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Oğuz UyaroğluDepartment of Internal Medicine, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Mine Durusu TanriöverDepartment of Internal Medicine, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Nursel Çalık BaşaranDepartment of Internal Medicine, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Gamze DurhanDepartment of Radiology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Figen DemirkazıkDepartment of Radiology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Hacettepe University · TRHacettepe University Hospital · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe aimed to analyze the usefulness of such a reserved area for the admission of the patients' symptoms suggesting COVID-19 and compare the demographic and clinical characteristics of the patients with COVID-19 and without COVID-19 who were admitted to C1 during the first month of the COVID-19 outbreak in our hospital.

methodsA new area was set up in Hacettepe University Adult Hospital to limit the contact of COVID-19 suspicious patients with other patients, which was named as COVID-19 First Evaluation Outpatient Clinic (C1). C1 had eight isolation rooms and two sampling rooms for SARS-CoV-2 polymerase-chain-reaction (PCR). All rooms were negative-pressurized. Patients who had symptoms that were compatible with COVID-19 were referred to C1 from pretriage areas. All staff received training for the appropriate use of personal protective equipment and were visited daily by the Infection Prevention and Control team.

resultsOne hundred and ninety-eight (29.4%) of 673 patients who were admitted to C1were diagnosed with COVID-19 between March 20, 2020, and April 19, 2020. SARS-CoV-2 PCR was positive in 142 out of 673 patients. Chest computerized tomography (CT) was performed in 421 patients and COVID-19 was diagnosed in 56 of them based on CT findings despite negative PCR. Four hundred and ninety-three patients were tested for other viral and bacterial infections with multiplex real-time reverse-transcriptase PCR (RTPCR). Blood tests that included complete blood count, renal and liver functions, d-dimer levels, ferritin, C- reactive protein, and procalcitonin were performed in 593 patients. Only one out of 44 healthcare workers who worked at C1 was infected by SARS-CoV-2. DISCUSSION: Early diagnosis of infected patients and ensuring adequate isolation are very important to control the spread of COVID-19. The purpose of setting up the COVID-19 first evaluation outpatient clinic was to prevent the overcrowding of ER due to mild or moderate infections, ensure appropriate distancing and isolation, and enable emergency services to serve for real emergencies. A wellplanned outpatient care area and teamwork including internal medicine, microbiology, and radiology specialists under the supervision of infectious diseases specialists allowed adequate management of the mild-to-moderate patients with suspicion of COVID-19.

Indexed as

COVID-19AdultAmbulatory Care FacilitiesHospitals, UniversityHumansSARS-CoV-2Turkeycoronavirus disease 2019COVID-19outpatient clinicSARS-CoV-2Severe acute respiratory syndrome coronavirus 2

Identifiers

PMID34493032
PMCPMC10734817
OpenAlexW3197929335

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.